LALPATHLAB — Dr. Lal PathLabs Share News
0.000.00%
Last trade - 00:00- IN₹311.00bn
- IN₹299.44bn
- IN₹27.63bn
India's Dr Lal Path Labs beats quarterly profit view on medical testing boom
Brief: Dr. Lal Pathlabs Launches Advanced Test For Amyloidosis
India's Metropolis Healthcare gains on upbeat Q3 earnings
India's Dr. Lal Pathlabs gains on higher Q3 profit
India's Dr Lal Path Labs posts higher Q3 profit on steady testing demand
Brief: Dr. Lal Pathlabs Approves Voluntary Liquidation Of Subsidiary Suburban Diagnostics
Brief: Max India Says Antara Senior Care Collaborates With Dr. Lal Pathlabs
India's Dr Lal Path Labs posts bigger-than-expected Q2 profit on demand for medical tests
Brief: Dr. Lal Pathlabs Q2 Consol Net Profit 1.29 Bln Rupees
Fewer dengue cases in India's Delhi to weigh on Dr Lal Pathlabs' Q2, Nomura says
Brief: Lal Pathlabs Says Kenya Unit Has Been Dissolved
Brief: Lal Pathlabs- Ved Prakash Goel Designated As Group Chief Financial Officer
India's Dr Lal PathLabs tops Q1 profit estimates on strong testing demand
India's Dr. Lal PathLabs extends gains on Q1 profit beat
Brief: Dr. Lal Pathlabs Q1 Consol Net Profit 1.06 Billion Rupees Ibes Profit Est. 992.7 Million Rupees
India's Krsna Diagnostics gains on strong Q1 results
India's Thyrocare Technologies jumps on Q1 profit jump
India's Dr. Lal PathLabs extends gains after Q4 results
India's Dr. LalPath Labs posts higher Q4 profit rises on healthy testing demand